A Systematic Review and Meta-Analysis of the Incidence and Risk Factors for Major Adverse Cardiovascular Events in Patients with Unrepaired Abdominal Aortic Aneurysms

被引:4
|
作者
Sharma, Chinmay [1 ]
Singh, Tejas P. [2 ]
Thanigaimani, Shivshankar [1 ,3 ]
Nastasi, Domenico [4 ]
Golledge, Jonathan [1 ,2 ,3 ]
机构
[1] James Cook Univ, Coll Med & Dent, Queensland Res Ctr Peripheral Vasc Dis, Townsville, Qld 4811, Australia
[2] Townsville Univ Hosp, Dept Vasc & Endovascular Surg, Townsville, Qld 4811, Australia
[3] James Cook Univ, Australian Inst Trop Hlth & Med, Townsville, Qld 4811, Australia
[4] Gold Coast Univ Hosp, Dept Vasc & Endovascular Surg, Southport, Qld 4215, Australia
基金
澳大利亚国家健康与医学研究理事会;
关键词
abdominal aortic aneurysm; cardiovascular death; myocardial infarction; stroke; MORTALITY; DISEASE; SURVEILLANCE; PREVENTION; DIAMETER;
D O I
10.3390/biomedicines11041178
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Major adverse cardiovascular events (MACE), including myocardial infarction (MI), stroke and cardiovascular death, cause substantial morbidity and mortality. This review assessed the incidence rate of MACE and the association with modifiable risk factors (diabetes, hypertension) and medication use (aspirin, statins) in patients with unrepaired abdominal aortic aneurysm (AAA). Electronic databases were searched systematically for observational studies reporting the incidence of MI, stroke or cardiovascular death in patients with unrepaired AAAs. The primary outcome was cardiovascular death reported as an incidence rate (events per 100 person-years (PY)). Fourteen studies, including 69,579 participants with a mean follow-up time of 5.4 years, were included. Meta-analysis revealed the overall incidence of cardiovascular death, MI and stroke of 2.31 per 100 PY (95% CI, 1.63-3.26; I-2 = 98%), 1.65 per 100 PY (95% CI, 1.01-2.69, I-2 = 88%) and 0.89 per 100 PY (95% CI, 0.53-1.48, I-2 = 87.0%), respectively. The mean rates of statin and aspirin prescriptions were 58.1% and 53.5%, respectively. In conclusion, there is a substantial incidence of MACE in patients with unrepaired AAA, but the prescription of preventative medication is suboptimal. Greater emphasis should be placed on secondary prevention in this population.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] INCIDENCE OF ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH INSOMNIA: A SYSTEMATIC REVIEW AND META-ANALYSIS OF REAL-WORLD DATA
    Aamir, Muhammad
    Ali, Eman
    Shaikh, Asim
    Sheikh, Ayesha
    Owais, Rabia
    Yasmin, Farah
    Abbas, Fatima Sughra
    Waqas, Muhammad A.
    Vyas, Apurva Vijay
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 1680 - 1680
  • [22] Effects of Smoking on Major Adverse Cardiovascular Events in Patients With Coronary Artery Spasm: A Systematic Review and Meta-Analysis
    Yang, Lei
    Wang, Kun
    Yang, Jie
    Hu, Fang-Xiao
    HEART LUNG AND CIRCULATION, 2024, 33 (09): : 1259 - 1271
  • [23] The effect of statin on major adverse cardiovascular events and mortality in patients with rheumatoid arthritis - a systematic review and meta-analysis
    Rahmadi, A. R.
    Pranata, R.
    Raffaello, W. M.
    Yonas, E.
    Ramadhian, M. P.
    Natadikarta, M. R. R.
    Akbar, M. R.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (09) : 3171 - 3178
  • [24] Polypill Therapy and Risk of Adverse Cardiovascular Events and Mortality: A Systematic Review and Meta-Analysis
    Rao, Shreya
    Siddiqi, Tariq Jamal
    Khan, Mohammad S.
    Michos, Erin
    Navar, Ann M.
    Wang, Thomas J.
    Greene, Stephen J.
    Prabhakaran, Dorairaj
    Khera, Amit
    Pandey, Ambarish
    CIRCULATION, 2021, 144
  • [25] Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis
    Singh, Sonal
    Loke, Yoon K.
    Spangler, John G.
    Furberg, Curt D.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2011, 183 (12) : 1359 - 1366
  • [26] ACE inhibitors for preventing major cardiovascular events in high risk patients: a systematic review and meta-analysis
    Berwanger, O.
    Avezum, A.
    Duncan, B. B.
    Rosito, G.
    Piegas, L.
    EUROPEAN HEART JOURNAL, 2005, 26 : 623 - 623
  • [27] Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta-analysis of randomized controlled trials
    Rungapiromnan, W.
    Yiu, Z. Z. N.
    Warren, R. B.
    Griffiths, C. E. M.
    Ashcroft, D. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 176 (04) : 890 - 901
  • [28] Combination therapy with long-acting bronchodilators and the risk of major adverse cardiovascular events in patients with COPD: a systematic review and meta-analysis
    Yang, Mingjin
    Li, Yishi
    Jiang, Youfan
    Guo, Shuliang
    He, Jian-Qing
    Sin, Don D.
    EUROPEAN RESPIRATORY JOURNAL, 2023, 61 (02)
  • [29] Incidence and type of adverse events in patients taking vonoprazan: A systematic review and meta-analysis
    Xu, Wentao
    Bai, Zhaohui
    Shang, Yiyang
    Wang, Jing
    Wong, Yujun
    Qi, Xingshun
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
  • [30] Predicting major adverse cardiovascular events for secondary prevention: protocol for a systematic review and meta-analysis of risk prediction models
    Akyea, Ralph K.
    Leonardi-Bee, Jo
    Asselbergs, Folkert W.
    Patel, Riyaz S.
    Durrington, Paul
    Wierzbicki, Anthony S.
    Ibiwoye, Oluwaseun H.
    Kai, Joe
    Qureshi, Nadeem
    Weng, Stephen F.
    BMJ OPEN, 2020, 10 (07):